(Q42542628)

2 November 2017

Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension (English)

1 reference

2 November 2017

21

1 reference

2 November 2017

22

1 reference

2 November 2017

Laura Southgate

8

0 references

Graham M Lord

object named as

Graham M Lord

11

0 references

Marc Humbert

object named as

Marc Humbert

19

0 references

author name string

Md Talat Nasim

1

1 reference

2 November 2017

Takeshi Ogo

2

1 reference

2 November 2017

Mohammad Ahmed

3

1 reference

2 November 2017

Rebecca Randall

4

1 reference

2 November 2017

Hasnin M Chowdhury

5

1 reference

2 November 2017

Katie M Snape

6

1 reference

2 November 2017

Teisha Y Bradshaw

7

1 reference

2 November 2017

Grace J Lee

9

1 reference

2 November 2017

Ian Jackson

10

1 reference

2 November 2017

J Simon R Gibbs

12

1 reference

2 November 2017

Martin R Wilkins

13

1 reference

2 November 2017

Keiko Ohta-Ogo

14

1 reference

2 November 2017

Kazufumi Nakamura

15

1 reference

2 November 2017

Barbara Girerd

16

1 reference

2 November 2017

Florence Coulet

17

1 reference

2 November 2017

Florent Soubrier

18

1 reference

2 November 2017

Nicholas W Morrell

20

1 reference

2 November 2017

11 October 2011

1 reference

2 November 2017

1 reference

2 November 2017

32

1 reference

2 November 2017

1385-1389

1 reference

2 November 2017

12

1 reference

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

2 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

SMAD4 mutations found in unselected HHT patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

SMAD4 mutation and the combined syndrome of juvenile polyposis syndrome and hereditary haemorrhagic telangiectasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Automated splicing mutation analysis by information theory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.21605

21 January 2018

Identifiers

DOI

10.1002/HUMU.21605

1 reference

2 November 2017

1 reference